Pinned
We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs @K5Global and others. 🧠🧠
Read the release:
Synchron
531 posts
Synchron
@synchroninc
Building brain computer interface technology to restore, extend and protect human agency in an age of accelerating intelligence.
- We’re honored to announce the first human #BCI implant using an #endovascular approach in the United States. This is a historic milestone for #humanity, which will forever change how people with #paralysis interact with the world. businesswire.com/news/home/2022…
00:00 
- Excited to announce the first use of @Apple #VisionPro with a #BCI system. 🧠🧠 Mark, a 64-year old man with ALS successfully used his direct thoughts to control the cursor on the Apple Vision Pro. Read the release:
- my hope is that I'm paving the way for people to tweet through thoughts phil
- We’re excited to announce completion of patient enrollment in our US-based COMMAND trial to assess our Synchron Switch™ motor neuroprosthesis in patients with severe paralysis. 🧠@MountSinaiNYC @Jacobs_Med_UB @UPMC #BCI Read our press release: shorturl.at/krIMY
- “Forget the headlines—@neuralink may be louder, but Synchron is further along. It reached FDA trials first, secured a global IP footprint, and partnered with @nvidia. Boards betting on visibility over defensibility may be backing the wrong horse." "While Neuralink commands
- Watch Rodney control his electronics using his mind - powered by Synchron BCI + NVIDIA Holoscan + Apple Vision Pro.
- 🧠 The positive results of our COMMAND trial - evaluating the safety and efficacy of our #BCI in 6 participants over 12 months - are live. Congratulations to our participants and partners: @MountSinaiNYC @UB_Neurosurgery @UPMC @CarnegieMellon shorturl.at/zotpD
- Hello 2023! At the end of the year, we announced that we had raised a series C round. As we enter the new year, we're excited to use the funds to accelerate product development and advance Synchron toward BCI market approval. Cheers to another year of hard work!
- Honored to share that Synchron is a member of the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC). We’re proud to be driving patient-first innovation in #BCI alongside our fellow signatories.
- There are 5 Million people in the USA living with paralysis that could potentially benefit from our #stentrode #bci If you or someone you care for is interested in learning more about our ongoing clinical trial in the USA, please email: [email protected]
